Investing Profile
John Glasspool
Your Intro Paths to John Glasspool
Signal uses Gmail to reveal intro paths. Email content is never read.
Sign in with Google →Current Investing Position
Agent Capital Venture Partner
Investment Range
$250K - $15.0M
Sweet Spot
$7.5M
John Glasspool is on these Sector & Stage Rankings
John Glasspool's Experience
Member of the Board Emerging Companies Section Governing Board Biotechnology Innovation Organization2022 - Present
Board Member Relmada Therapeutics, Inc2019 - Present
CEO and President Anthos Therapeutics Inc2019 - Present
Venture Partner Agent Capital2018 - Present
Senior Advisor Massachusetts Institute of Technology- NEWDIGS2016 - Present
Board Member DalCor Pharmaceuticals2017 - 2023
Consultant Roivant Sciences2017 - 2018
EVP, Head of Corporate Strategy and Customer Operations Baxalta2015 - 2017
VP, Head of Emerging Therapies and Market Development, Bioscience Baxter International Inc.2012 - 2015
Head Region Europe - Vaccines & Diagnostic Novartis2009 - 2012
Global Head Pharma Commercial Operations, Pricing and Market Access Novartis2008 - 2009
Head of Cardiovascular & Metabolism Franchise Novartis2004 - 2008
Head of Neuroscience Franchise Novartis2003 - 2004
Head of Marketing Neurology Novartis2002 - 2003
Head of Marketing NS Novartis2002 - 2003
Director Strategic Marketing Johnson and Johnson1991 - 2002
Sales Representative Scotia1990 - 1991
John Glasspool's Education
Oxford Brookes University Diploma in Business Administration
Tufts Center for the Study of Drug Development Postgraduate Course in Clinical Pharmacology, Development & Regulation
University of Staffordshire Bachelor of Arts (B.A.) Politics and International Relations
Founders who looked at John Glasspool's profile also looked at these Scouts & Angels